Latest Partnerships News

Comms Group reported robust FY25 results driven by domestic expansion, including the strategic acquisition of TasmaNet, and strong international growth in its Global and Wholesale division.

Elixir Energy secures $16.6 million in a capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to define reserves in Queensland’s Taroom Trough. This funding accelerates appraisal drilling and production testing, positioning Elixir for a pivotal year ahead.

Elixir Energy secures a $16.6 million capital raise led by Omega Oil and Gas, unlocking Phase-2 of its strategic plan to advance appraisal and production testing in Queensland’s Taroom Trough.

Pure Foods Tasmania has acquired premium ice cream brand Elato, integrating it with its Cashew Creamery to form a new Ice Cream Division led by Elato’s founder. This move broadens PFT’s product range and leverages existing manufacturing capabilities.

New Frontier Minerals has raised $2.25 million to fast-track development of its Harts Range rare earths project, leveraging a promising new processing technology from Metallium Ltd. The capital injection supports an imminent drilling campaign and advances a mining lease application in Queensland.

Mesoblast Limited forecasts a significant jump in quarterly revenue, driven by strong sales of its FDA-approved cell therapy Ryoncil. The company’s latest update highlights robust growth and ongoing expansion in inflammatory disease treatments.

Stakk Limited has expanded its partnership with T-Mobile Money, adding advanced fraud and risk modules to its embedded finance platform, potentially accelerating revenue growth within one of the largest US consumer ecosystems.

Renascor Resources has hit key construction milestones at its Australian Government co-funded Purified Spherical Graphite (PSG) demonstration facility, maintaining schedule for on-site commissioning this quarter. The project aims to establish a competitive, HF-free PSG supply chain outside China.

Mesoblast has achieved a landmark FDA approval for RYONCIL, the first allogeneic mesenchymal stromal cell therapy, driving strong commercial momentum and advancing a robust pipeline targeting inflammatory diseases.

Astron Limited has sold a significant portion of its Energy Fuels shares, generating A$15.2 million to bolster financial flexibility as it advances the pivotal Donald Project towards production.

IVE Group Limited reported a robust FY25 with significant profit growth and margin expansion, driven by strategic logistics expansions and the rising Lasoo e-commerce platform. Despite a softer FY26 start, the company maintains steady dividends and growth ambitions.

Clarity Pharmaceuticals has raised $203 million to accelerate its copper-64 and copper-67 radiopharmaceutical pipeline, targeting prostate and neuroendocrine cancers with multiple FDA Fast Track trials underway.